< Back to Find a Trial A Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION) Phase Phase III Status Open Intervention AMX0035 Principal Investigator Julio Rojas, MD, PhD [email protected] 415-502-7341 Sponsor Amylyx Pharmaceuticals Inc. Contact Coordinator Aedan Enriquez [email protected] 415-476-9578 Please visit ClinicalTrials.gov for more information.